Format

Send to

Choose Destination
Plast Reconstr Surg. 2011 May;127(5):2136-7; author reply 2137. doi: 10.1097/PRS.0b013e31820e9405.

Excising value at a marginal cost: rethinking the management of Basal cell carcinoma.

PMID:
21532456
DOI:
10.1097/PRS.0b013e31820e9405
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center